Jacob M. Chacko
2023
In 2023, Jacob M. Chacko earned a total compensation of $3.2M as President and Chief Executive Officer at Oric Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $350,200 |
|---|---|
| Option Awards | $1,796,080 |
| Salary | $596,083 |
| Stock Awards | $396,000 |
| Other | $14,720 |
| Total | $3,153,083 |
Chacko received $1.8M in option awards, accounting for 57% of the total pay in 2023.
Chacko also received $350.2K in non-equity incentive plan, $596.1K in salary, $396K in stock awards and $14.7K in other compensation.
Rankings
In 2023, Jacob M. Chacko's compensation ranked 270th out of 2,647 executives tracked by ExecPay. In other words, Chacko earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 270 out of 2,647 | 90th |
Division Manufacturing | 146 out of 1,447 | 90th |
Major group Chemicals And Allied Products | 100 out of 817 | 88th |
Industry group Drugs | 97 out of 783 | 88th |
Industry Pharmaceutical Preparations | 61 out of 555 | 89th |
Source: SEC filing on April 24, 2024.
Chacko's colleagues
We found two more compensation records of executives who worked with Jacob M. Chacko at Oric Pharmaceuticals in 2023.
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021